Systemic inflammation mediates the link between metabolic syndrome and colorectal cancer risk: insights from a large prospective cohort
Postgraduate Medical Journal · 21.07.2026 · 102 (1210) · 715-724
DOI: 10.1093/postmj/qgag007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, online erschienen am 29.01.2026. Verfasst von Wenwen Lv und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetics and Development of Complex Phenotypes, Center for Evolutionary Biology, School of Life Sciences, Fudan University, 2…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Colorectal Neoplasms, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission Clinical Research Special Program, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The relationship between metabolic syndrome (MetS) and colorectal cancer (CRC) remains incompletely understood, with chronic inflammation hypothesized as a potential mediator. This study aimed to investigate associations among MetS, systemic inflammation biomarkers, and CRC risk, while focusing on the mediating role of inflammation.
Methods
Using data from 335 544 participants in the UK Biobank, we assessed associations between MetS, CRC risk, and six systemic inflammation biomarkers [neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and inflammatory burden index (IBI)]. Fine and Gray’s competing risk model, multivariable linear regression, and Cox proportional hazards models were employed. Causal mediation analysis was used to evaluate the mediating effects of inflammation biomarkers.
Results
MetS was associated with increased CRC risk (HR = 1.11, 95% CI = 1.03–1.20, P = .007), with central obesity and hyperglycemia showing the strongest associations. Five inflammation biomarkers (NLR, PLR, SII, SIRI, and IBI) were positively associated with both MetS and CRC risk. Mediation analysis revealed that these biomarkers partially mediated the MetS–CRC relationship, with IBI accounting for the largest mediating effects (16.6%).
Conclusion
This study confirms that both MetS and systemic inflammation contribute to increased CRC risk, with inflammation playing a significant mediating role. These findings provide novel insights into underlying mechanisms and highlight the potential of inflammation biomarkers, particularly IBI, for improving early CRC risk prediction in individuals with metabolic dysfunction. Key messages What is already known on this topic: Metabolic syndrome (MetS) is associated with an increased colorectal cancer (CRC) risk, but the biological pathway remains incompletely understood. Systemic low-grade inflammation has been proposed as a mediator, yet composite inflammation indices are underexplored. What this study adds: In 335 544 UK Biobank participants, MetS was associated with a higher risk of CRC (HR = 1.11, 95% CI 1.03–1.20). Five systemic inflammation biomarkers (NLR, PLR, SII, SIRI, and IBI) were associated with both MetS and CRC. Mediation analysis indicated partial mediation, with IBI contributing the largest proportion (16.6%). How this study might affect research, practice, or policy: Incorporating systemic inflammation indices, particularly IBI, may improve early risk stratification for CRC among individuals with MetS. These findings support the development of prevention strategies targeting low-grade inflammation, while guiding future mechanistic and translational research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetics and Development of Complex Phenotypes, Center for Evolutionary Biology, School of Life Sciences, Fudan University, 2005 Songhu Road, Yangpu District, Shanghai 200438, China.
- Institute of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Huangpu District, Shanghai 200025, China.
- Clinical Research Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Xuhui District, Shanghai 200233, China.
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), 207 Ruijing Er Road, Huangpu District, Shanghai 200025, China.
- Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 17 Lujiang Road, Luyang District, Hefei, Anhui 230031, China.
ORCID-Profile: Shuhua Xu
Förderung
- Shanghai Municipal Health Commission Clinical Research Special Program
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shanghai Science and Technology Commission Program
- Shanghai Science and Technology Commission
- Shanghai Jiao Tong University School of Medicine Project
- Office of Global Partnerships
Zitieren
APA
Lv, W., Wang, S., Duan, L., Dong, Z., Zhu, H., Wang, G., Yu, Z., & Xu, S. (2026). Systemic inflammation mediates the link between metabolic syndrome and colorectal cancer risk: insights from a large prospective cohort. Postgraduate Medical Journal, 102(1210), 715-724. https://doi.org/10.1093/postmj/qgag007
Vancouver
Lv W, Wang S, Duan L, Dong Z, Zhu H, Wang G, et al. Systemic inflammation mediates the link between metabolic syndrome and colorectal cancer risk: insights from a large prospective cohort. Postgraduate Medical Journal. 2026;102(1210):715-724. doi:10.1093/postmj/qgag007
BibTeX
@article{Lv2026,
author = {Lv, Wenwen and Wang, Suna and Duan, Lei and Dong, Zhongxun and Zhu, Hai and Wang, Gang and Yu, Zhangsheng and Xu, Shuhua},
title = {Systemic inflammation mediates the link between metabolic syndrome and colorectal cancer risk: insights from a large prospective cohort},
journal = {Postgraduate Medical Journal},
year = {2026},
volume = {102},
number = {1210},
pages = {715--724},
doi = {10.1093/postmj/qgag007}
}
EUVIMED